Mako Surgical’s portfolio is shaped by the quality of individual inventions. Their patents carry well-constructed claims across the full range of technology domains in robotic surgery, with related follow-on filings that deepen protection around core assets. Their strongest single patent represents a notable peak within the portfolio. Revenue and R&D spending both show consistent growth, reflecting a business building on a quality-first foundation. Mako Surgical is a wholly owned subsidiary of Stryker Corporation and files patents under the Mako Surgical name.
